Ontrak, Inc. (OTRK)
USD 1.57
(3.97%)
USD 1.57
(3.97%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.74 Million USD | -12.2% |
| 2022 | 14.51 Million USD | -82.75% |
| 2021 | 84.13 Million USD | 1.56% |
| 2020 | 82.83 Million USD | 136.04% |
| 2019 | 35.09 Million USD | 131.24% |
| 2018 | 15.17 Million USD | 96.67% |
| 2017 | 7.71 Million USD | 9.07% |
| 2016 | 7.07 Million USD | 161.55% |
| 2015 | 2.7 Million USD | 33.25% |
| 2014 | 2.03 Million USD | 134.41% |
| 2013 | 866 Thousand USD | 60.07% |
| 2012 | 541 Thousand USD | 102.62% |
| 2011 | 267 Thousand USD | -40.4% |
| 2010 | 448 Thousand USD | -70.72% |
| 2009 | 1.53 Million USD | -96.29% |
| 2008 | 41.23 Million USD | -6.3% |
| 2007 | 44 Million USD | 1026.5% |
| 2006 | 3.9 Million USD | 235.57% |
| 2005 | 1.16 Million USD | 506.25% |
| 2004 | 192 Thousand USD | 156.0% |
| 2003 | 75 Thousand USD | -97.19% |
| 2002 | 2.67 Million USD | 72.5% |
| 2001 | 1.54 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.68 Million USD | -24.27% |
| 2024 Q2 | 2.45 Million USD | -8.54% |
| 2023 Q1 | 2.52 Million USD | 0.76% |
| 2023 Q3 | 3.71 Million USD | 25.51% |
| 2023 Q4 | 3.53 Million USD | -4.74% |
| 2023 FY | 12.74 Million USD | -12.2% |
| 2023 Q2 | 2.96 Million USD | 17.04% |
| 2022 Q1 | 5.25 Million USD | -49.11% |
| 2022 Q3 | 2.84 Million USD | -27.16% |
| 2022 Q4 | 2.51 Million USD | -11.71% |
| 2022 FY | 14.51 Million USD | -82.75% |
| 2022 Q2 | 3.9 Million USD | -25.77% |
| 2021 Q4 | 10.33 Million USD | -44.43% |
| 2021 Q1 | 28.72 Million USD | -1.81% |
| 2021 Q3 | 18.59 Million USD | -29.79% |
| 2021 FY | 84.13 Million USD | 1.56% |
| 2021 Q2 | 26.48 Million USD | -7.79% |
| 2020 Q4 | 29.25 Million USD | 21.77% |
| 2020 Q3 | 24.02 Million USD | 39.45% |
| 2020 Q2 | 17.22 Million USD | 39.62% |
| 2020 Q1 | 12.33 Million USD | 4.93% |
| 2020 FY | 82.83 Million USD | 136.04% |
| 2019 Q3 | 8.84 Million USD | 15.15% |
| 2019 FY | 35.09 Million USD | 131.24% |
| 2019 Q1 | 6.81 Million USD | 21.11% |
| 2019 Q2 | 7.68 Million USD | 12.77% |
| 2019 Q4 | 11.75 Million USD | 32.93% |
| 2018 Q3 | 4.36 Million USD | 33.49% |
| 2018 Q1 | 1.91 Million USD | -37.03% |
| 2018 FY | 15.17 Million USD | 96.67% |
| 2018 Q2 | 3.27 Million USD | 71.27% |
| 2018 Q4 | 5.62 Million USD | 28.73% |
| 2017 Q2 | 1.66 Million USD | -8.62% |
| 2017 FY | 7.71 Million USD | 9.07% |
| 2017 Q4 | 3.03 Million USD | 153.97% |
| 2017 Q3 | 1.19 Million USD | -28.23% |
| 2017 Q1 | 1.82 Million USD | -51.9% |
| 2016 Q3 | 1.33 Million USD | 9.24% |
| 2016 FY | 7.07 Million USD | 161.55% |
| 2016 Q4 | 3.78 Million USD | 183.53% |
| 2016 Q2 | 1.22 Million USD | 67.99% |
| 2016 Q1 | 728 Thousand USD | -42.31% |
| 2015 FY | 2.7 Million USD | 33.25% |
| 2015 Q1 | 433 Thousand USD | -62.32% |
| 2015 Q2 | 472 Thousand USD | 9.01% |
| 2015 Q3 | 538 Thousand USD | 13.98% |
| 2015 Q4 | 1.26 Million USD | 134.57% |
| 2014 Q2 | 312 Thousand USD | 43.12% |
| 2014 FY | 2.03 Million USD | 134.41% |
| 2014 Q4 | 1.14 Million USD | 210.54% |
| 2014 Q3 | 370 Thousand USD | 18.59% |
| 2014 Q1 | 218 Thousand USD | -53.42% |
| 2013 FY | 866 Thousand USD | 60.07% |
| 2013 Q4 | 468 Thousand USD | 260.0% |
| 2013 Q1 | 135 Thousand USD | -24.58% |
| 2013 Q2 | 133 Thousand USD | -1.48% |
| 2013 Q3 | 130 Thousand USD | -2.26% |
| 2012 Q1 | 93 Thousand USD | 55.0% |
| 2012 FY | 541 Thousand USD | 102.62% |
| 2012 Q4 | 179 Thousand USD | 27.86% |
| 2012 Q3 | 140 Thousand USD | 8.53% |
| 2012 Q2 | 129 Thousand USD | 38.71% |
| 2011 Q2 | 63 Thousand USD | -27.59% |
| 2011 Q1 | 87 Thousand USD | -20.91% |
| 2011 FY | 267 Thousand USD | -40.4% |
| 2011 Q4 | 60 Thousand USD | 5.26% |
| 2011 Q3 | 57 Thousand USD | -9.52% |
| 2010 Q3 | 104 Thousand USD | -6.31% |
| 2010 Q1 | 123 Thousand USD | -33.15% |
| 2010 FY | 448 Thousand USD | -70.72% |
| 2010 Q2 | 111 Thousand USD | -9.76% |
| 2010 Q4 | 110 Thousand USD | 5.77% |
| 2009 Q4 | 184 Thousand USD | -31.34% |
| 2009 Q2 | 371 Thousand USD | -47.52% |
| 2009 Q3 | 268 Thousand USD | -27.76% |
| 2009 Q1 | 707 Thousand USD | -91.8% |
| 2009 FY | 1.53 Million USD | -96.29% |
| 2008 Q3 | 9.65 Million USD | -16.83% |
| 2008 Q2 | 11.61 Million USD | 2.42% |
| 2008 Q1 | 11.33 Million USD | -3.78% |
| 2008 FY | 41.23 Million USD | -6.3% |
| 2008 Q4 | 8.62 Million USD | -10.75% |
| 2007 Q2 | 11.34 Million USD | 28.03% |
| 2007 FY | 44 Million USD | 1026.5% |
| 2007 Q4 | 11.78 Million USD | -1.96% |
| 2007 Q3 | 12.02 Million USD | 6.0% |
| 2007 Q1 | 8.85 Million USD | 776.93% |
| 2006 Q3 | 1.07 Million USD | -8.62% |
| 2006 Q1 | 653 Thousand USD | 76.49% |
| 2006 FY | 3.9 Million USD | 235.57% |
| 2006 Q4 | 1.01 Million USD | -5.7% |
| 2006 Q2 | 1.17 Million USD | 79.48% |
| 2005 Q1 | 203 Thousand USD | 156.96% |
| 2005 FY | 1.16 Million USD | 506.25% |
| 2005 Q4 | 370 Thousand USD | 2.49% |
| 2005 Q3 | 361 Thousand USD | 56.96% |
| 2005 Q2 | 230 Thousand USD | 13.3% |
| 2004 Q2 | 5000.00 USD | -92.54% |
| 2004 FY | 192 Thousand USD | 156.0% |
| 2004 Q4 | 79 Thousand USD | 92.68% |
| 2004 Q3 | 41 Thousand USD | 720.0% |
| 2004 Q1 | 67 Thousand USD | 116.13% |
| 2003 Q3 | 44 Thousand USD | 0.0% |
| 2003 Q1 | 285.95 Thousand USD | -70.22% |
| 2003 Q2 | - USD | -100.0% |
| 2003 FY | 75 Thousand USD | -97.19% |
| 2003 Q4 | 31 Thousand USD | -29.55% |
| 2002 Q3 | 1.16 Million USD | 127.22% |
| 2002 Q4 | 960.14 Thousand USD | -17.81% |
| 2002 Q1 | 29.37 Thousand USD | 0.0% |
| 2002 Q2 | 514.11 Thousand USD | 1650.36% |
| 2002 FY | 2.67 Million USD | 72.5% |
| 2001 FY | 1.54 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ontrak, Inc. | 12.74 Million USD | 0.0% |
| iCoreConnect Inc. | 8.15 Million USD | -56.325% |
| Augmedix, Inc. | 44.85 Million USD | 71.591% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.856% |
| CareCloud, Inc. | 117.05 Million USD | 89.114% |
| CareCloud, Inc. | 117.05 Million USD | 89.114% |
| HealthEquity, Inc. | 999.58 Million USD | 98.725% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 98.091% |
| Nutex Health, Inc. | 247.64 Million USD | 94.854% |
| OneMedNet Corporation | 1.02 Million USD | -1147.295% |
| Progyny, Inc. | 1.08 Billion USD | 98.829% |
| Omnicell, Inc. | 1.14 Billion USD | 98.889% |
| Renalytix Plc | 2.28 Million USD | -456.706% |
| Schrödinger, Inc. | 216.66 Million USD | 94.119% |
| Simulations Plus, Inc. | 70.01 Million USD | 81.799% |
| SOPHiA GENETICS SA | 62.37 Million USD | 79.569% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | 43.605% |
| Minerva Surgical, Inc. | 50.29 Million USD | 74.663% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.935% |
| Sharecare, Inc. | 445.25 Million USD | 97.138% |
| Aclarion, Inc. | 75.4 Thousand USD | -16799.634% |
| CareMax, Inc. | 751.1 Million USD | 98.303% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -19504.615% |
| Forian Inc. | 20.48 Million USD | 37.782% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -19504.615% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 93.709% |
| SCWorx Corp. | 3.8 Million USD | -234.906% |
| Definitive Healthcare Corp. | 251.41 Million USD | 94.931% |
| 10x Genomics, Inc. | 618.72 Million USD | 97.94% |
| Zhongchao Inc. | 19.43 Million USD | 34.429% |
| Accolade, Inc. | 414.29 Million USD | 96.924% |
| MSP Recovery, Inc. | 7.7 Million USD | -65.386% |
| R1 RCM Inc. | 2.25 Billion USD | 99.435% |
| Spok Holdings, Inc. | 139.02 Million USD | 90.834% |
| Privia Health Group, Inc. | 1.65 Billion USD | 99.231% |
| EUDA Health Holdings Limited | 3.7 Million USD | -243.805% |
| TruBridge, Inc. | 339.43 Million USD | 96.246% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.856% |
| Sharecare, Inc. | 445.25 Million USD | 97.138% |
| Health Catalyst, Inc. | 295.93 Million USD | 95.694% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 98.302% |
| Premier, Inc. | 1.34 Billion USD | 99.054% |
| HealthStream, Inc. | 279.06 Million USD | 95.434% |
| Certara, Inc. | 354.33 Million USD | 96.404% |
| GeneDx Holdings Corp. | 202.56 Million USD | 93.709% |
| SHL Telemedicine Ltd. | 57.07 Million USD | 77.673% |
| CareCloud, Inc. | 117.05 Million USD | 89.114% |
| EUDA Health Holdings Limited | 3.7 Million USD | -243.805% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -1642.054% |
| CareMax, Inc. | 751.1 Million USD | 98.303% |
| Healthcare Triangle, Inc. | 33.2 Million USD | 61.621% |
| National Research Corporation | 148.58 Million USD | 91.423% |
| Aclarion, Inc. | 75.4 Thousand USD | -16799.634% |
| OptimizeRx Corporation | 71.52 Million USD | 82.183% |